Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-29

Clinical Trial Update: Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification [Phase 4]

View source ↗

Summary

Phase 4 trial comparing aqueous absorption and pharmacokinetics of Besivance versus VIGAMOX in patients undergoing cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BESIVANCE (besifloxacin)
  • VIGAMOX (Moxifloxacin hydrochloride)

Snippet

Sponsor: Frank A. Bucci, Jr., M.D. | Conditions: Cataracts | Phase 4 | Status: COMPLETED | Results posted: 2019-10-29